High-Precision radiation joins fight against spreading esophageal cancer
NCT ID NCT07330583
Summary
This study is testing if adding a precise, high-dose radiation treatment (SBRT) to standard chemotherapy and immunotherapy helps people with esophageal cancer that has spread to a few other places in the body. It aims to better control the cancer and help patients live longer without their disease getting worse. The trial will enroll about 22 adults in Alberta, Canada.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.